CP
TMO icon

Clarendon Private’s Thermo Fisher Scientific TMO Stock Holding History

Clarendon Private’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$484K Sell
985
-250
-20% -$136K 0.37% 72
2025
Q4 		$716K Buy
1,235
+112
+10% +$63.3K 0.61% 46
2025
Q3 		$545K Buy
1,123
+325
+41% +$151K 0.49% 63
2025
Q2 		$324K Sell
798
-45
-5% -$18.8K 0.31% 84
2025
Q1 		$420K Sell
843
-2
-0.2% -$1.08K 0.44% 70
2024
Q4 		$440K Buy
+845
New +$465K 0.46% 63

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Clarendon Private's TMO Position: Q1 2026 in Review

Clarendon Private reduced its Thermo Fisher Scientific (TMO) stake by 20% in Q1 2026, selling an estimated $136K and leaving 985 shares worth $484K. The position accounts for 0.37% of the portfolio, ranked #72.

Clarendon Private first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $716K in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Clarendon Private held 985 shares of Thermo Fisher Scientific worth $484K as of Q1 2026.
  • Clarendon Private sold 250 Thermo Fisher Scientific shares in Q1 2026, an estimated $136K.
  • Thermo Fisher Scientific made up 0.37% of Clarendon Private's portfolio in Q1 2026, its #72 holding.
  • Clarendon Private first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
  • Clarendon Private's Thermo Fisher Scientific position peaked at $716K in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Clarendon Private's 13F filing for Q1 2026, filed 11 May 2026.